EICHORCondition: Multiple Myeloma · Sponsor: Oncotherapeutics
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who currently show progressive disease.
This description comes directly from the study's public registry record.
James R Berenson, MD · (310)623-1223 · jberenson@berensoncancercenter.com
Afra Yehwalashet · ayehu@oncotherapeutics.com
Always discuss trial participation with your own doctor first.
| Global Oncology, Inc. | Alhambra, California, United States | Recruiting |
| Comprehensive Blood and Cancer Center | Bakersfield, California, United States | Active Not Recruiting |
| California Cancer Associates for Research & Excellence (cCARE) | Encinitas, California, United States | Recruiting |
| Compassionate Care Research Group, Inc. | Fountain Valley, California, United States | Terminated |
| Robert A. Moss, M.D., F.A.C.P., Inc. | Fountain Valley, California, United States | Terminated |
| Pacific Cancer Care | Monterey, California, United States | Terminated |
| Sansum Clinic- Ridley-Tree Cancer Center | Santa Barbara, California, United States | Terminated |
| Wellness Oncology and Hematology | West Hills, California, United States | Recruiting |
| James R. Berenson M.D. Inc. | West Hollywood, California, United States | Recruiting |
| Cancer Specialists, LLC | Jacksonville, Florida, United States | Recruiting |
| Millennium Oncology Research Clinic | Pembroke Pines, Florida, United States | Terminated |
| Regional Cancer Care Associates (RCCA) MD, LLC | Bethesda, Maryland, United States | Active Not Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03110822